Ibrutinib: An FDA-approved medicine
The drug Ibrutinib is an inhibitor of Bruton’s tyrosine kinase (BTK). It is a white to off-white solid that healthcare professionals use to treat patients with mantle cell lymphoma (MCL) who have received at least one prior therapy, chronic lymphocytic leukemia (CLL) who have received at least one prior therapy, chronic lymphocytic leukemia (CLL) with 17p deletion and Waldenström’s macroglobulinemia. Ibrutinib forms a covalent bond with a cysteine residue in the BTK active site, leading to inhibition of BTK enzymatic activity. The capsules of Ibrutinib come in 140 mg strength to administer orally. Administer Ibrutinib orally once daily at approximately the same time each day. Swallow the capsules whole with water. Do not open, break, or chew the capsules.
Ibrutinib 140 mg price in India is inexpensive, and this drug is readily available from licensed pharmaceutical generic drug suppliers. For further information, please dial toll-free no. 18008891064.